Rein Therapeutics, Inc. (RNTX): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$157.0K
Year ended 2021-12-31
-67.1%
3-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2021-12-31 | $157.0K | n/m | 2023-03-20, From 2021-01-01 |
| 2020-12-31 | $5.0K | -96.7% | 2022-03-28, From 2020-01-01 |
| 2019-12-31 | $151.0K | -96.6% | 2021-03-24, From 2019-01-01 |
| 2018-12-31 | $4.42M | n/m | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | $142.0K | n/a | 2019-03-29, From 2017-01-01 |
| No annual figure between 2015-12-31 and 2017-12-31. | |||
| 2015-12-31 | $94.0K | n/a | 2018-04-02, From 2015-01-01 |